140 related articles for article (PubMed ID: 810132)
1. Canine erythrocyte pyruvate kinase. I. Properties of the normal enzyme.
Black JA; Chern CJ; Rittenberg MB
Biochem Genet; 1975 Jun; 13(5-6):331-9. PubMed ID: 810132
[TBL] [Abstract][Full Text] [Related]
2. Canine erythrocyte pyruvate kinase. II. Properties of abnormal enzyme associated with hemolytic anemia in the Basenji dog.
Standerfer RJ; Rittenberg MB; Chern CJ; Templeton JW; Black JA
Biochem Genet; 1975 Jun; 13(5-6):341-51. PubMed ID: 810133
[TBL] [Abstract][Full Text] [Related]
3. Comparative kinetic and electrophoretic properties of erythrocyte pyruvate kinases.
Beeson MA; Black JA
Comp Biochem Physiol B; 1976; 53(4):489-93. PubMed ID: 816594
[No Abstract] [Full Text] [Related]
4. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
[TBL] [Abstract][Full Text] [Related]
5. [Studies on erythrocyte pyruvate kinase. I. Some properties of the normal human enzyme].
Boivin P; Galand C; Demartial MC
Pathol Biol (Paris); 1972; 20(11):583-94. PubMed ID: 4558576
[No Abstract] [Full Text] [Related]
6. Functional changes associated with the sequential transformation of L'4 into L4 pyruvate kinase.
Sprengers ED; Staal GE
Biochim Biophys Acta; 1979 Oct; 570(2):259-70. PubMed ID: 497228
[TBL] [Abstract][Full Text] [Related]
7. Human erythrocyte pyruvate kinase. Total purification and evidence for its antigenic identity with L-type enzyme.
Marie J; Kahn A; Boivin P
Biochim Biophys Acta; 1977 Mar; 481(1):96-104. PubMed ID: 402946
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase deficiency hemolytic anemia: enzymatic characterization studies in twelve patients.
Shinohara K; Tanaka KR
Hemoglobin; 1980; 4(5-6):611-25. PubMed ID: 7440218
[TBL] [Abstract][Full Text] [Related]
9. Comparative kinetic behaviour and regulation by fructose-1,6-bisphosphate and ATP of pyruvate kinase from erythrocytes, reticulocytes and bone marrow cells.
Rodriguez-Horche P; Luque J; Perez-Artes E; Pineda M; Pinilla M
Comp Biochem Physiol B; 1987; 87(3):553-7. PubMed ID: 3621913
[TBL] [Abstract][Full Text] [Related]
10. A monomeric form of pyruvate kinase in human pyruvate kinase deficiency.
Adachi K; Ghory PK; Asakura T; Schwartz E
Proc Natl Acad Sci U S A; 1977 Feb; 74(2):501-4. PubMed ID: 15247
[TBL] [Abstract][Full Text] [Related]
11. A mutant of human red cell pyruvate kinase with high affinity for phosphoenolpyruvate.
Boivin P; Galand C
Enzyme; 1974; 18(1):37-47. PubMed ID: 4850232
[No Abstract] [Full Text] [Related]
12. Irreversible inactivation of human erythrocyte pyruvate kinase by 2,3-butanedione.
Kilinç K; Ozer N
Arch Biochem Biophys; 1984 Apr; 230(1):321-6. PubMed ID: 6712241
[TBL] [Abstract][Full Text] [Related]
13. Defective erythrocyte pyruvate kinase.
Staal GE; Ceerdink RP; Vlug AM; Hamelink ML
Clin Chim Acta; 1976 Apr; 68(1):11-5. PubMed ID: 1261049
[TBL] [Abstract][Full Text] [Related]
14. Pyruvate kinase activity and response to allosteric effectors in rat erythrocytes and reticulocytes fractionated by multiple partitioning in aqueous two-phase systems.
Pinilla M; Rodriguez-Horche P; Luque J
Cell Biochem Funct; 1987 Oct; 5(4):301-7. PubMed ID: 3677327
[TBL] [Abstract][Full Text] [Related]
15. Regulation of M2-type pyruvate kinase from human meningioma by allosteric effectors fructose 1,6 diphosphate and L-alanine.
Mellati AA; Yücel M; Altinörs N; Gündüz U
Cancer Biochem Biophys; 1992 Oct; 13(1):33-41. PubMed ID: 1343845
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic regulation of Rana balcanica erythrocyte pyruvate kinase.
Kaloyianni M; Cotoglou C; Giagtzoglou N
J Comp Physiol B; 2000 Mar; 170(2):85-90. PubMed ID: 10791568
[TBL] [Abstract][Full Text] [Related]
17. The immunological properties of pyruvate kinase. II. The relationship of the human erythrocyte isozyme to the human liver isozymes.
Lincoln DR; Black JA; Rittenberg MB
Biochim Biophys Acta; 1975 Dec; 410(2):279-84. PubMed ID: 54192
[TBL] [Abstract][Full Text] [Related]
18. Modification of human erythrocyte pyruvate kinase by an active site-directed reagent: bromopyruvate.
Acan NL; Ozer N
J Enzyme Inhib; 2001 Nov; 16(5):457-64. PubMed ID: 11916152
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte pyruvate kinase deficiency: relations of residual enzyme activity, altered regulation of defective enzymes and concentrations of high-energy phosphates with the severity of clinical manifestation.
Lakomek M; Neubauer B; von der Lühe A; Hoch G; Winkler H; Schröter W
Eur J Haematol; 1992 Aug; 49(2):82-92. PubMed ID: 1397245
[TBL] [Abstract][Full Text] [Related]
20. Conformational differences in the active sites of muscle and erythrocyte pyruvate kinase.
Jacobson KW; Black JA
J Biol Chem; 1971 Sep; 246(17):5504-9. PubMed ID: 5124501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
